A critical view of the effects of phytoestrogens on hot flashes and breast cancer risk

Jacquot, 2003, Recent advances in the development of phytoestrogens and derivatives: an update of the promising perspectives in the prevention of postmenopausal diseases, Mini Rev Med Chem, 3, 387, 10.2174/1389557033488006 Cherdshewasart, 2008, Metabolic activation promotes estrogenic activity of the phytoestrogen-rich plant, Maturitas, 59, 128, 10.1016/j.maturitas.2008.01.002 Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β, Endocrinology, 139, 4252, 10.1210/en.139.10.4252 Sotoca, 2008, Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on ERα/ERβ ratio, J Steroid Biochem Mol Biol, 112, 171, 10.1016/j.jsbmb.2008.10.002 Palmieri, 2002, Estrogen receptor beta in breast cancer, Endocr Relat Cancer, 9, 1, 10.1677/erc.0.0090001 Reiter, 2009, Isoflavones are safe compounds for therapeutical applications – evaluation of in vitro data, Gynecol Endocrinol, 25, 554, 10.1080/09513590802596461 Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 Beral, 2003, Breast cancer and hormone replacement therapy in the million women study, Lancet, 362, 419, 10.1016/S0140-6736(03)14596-5 Ravdin, 2007, The decrease in breast-cancer incidence in 2003 in the United States, N Engl J Med, 356, 1670, 10.1056/NEJMsr070105 Henderson, 1991, The international variation in breast cancer rates: an epidemiological assessment, Breast Cancer Res Treat, 18, S11, 10.1007/BF02633520 Taku, 2010, Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials, Bone, 47, 413, 10.1016/j.bone.2010.05.001 Lamon-Fava, 2000, Genistein activates apolipoprotein A-1 gene expression the human hepatoma cell line hep G2, J Nutr, 130, 2489, 10.1093/jn/130.10.2489 Godsland, 2001, Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published 1974–2000, Fertil Steril, 75, 898, 10.1016/S0015-0282(01)01699-5 Wangen, 2001, Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women, Am J Clin Nutr, 73, 225, 10.1093/ajcn/73.2.225 Jenkins, 2010, Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms, J Nutr, 140, 2302S, 10.3945/jn.110.124958 Sécurité et bénéfices des phyto-estrogènes apportés par l’alimentation, Recommandations. Rapport de l’Agence Française de Sécurité Sanitaire des Aliments, http://www.afssa.fr/Documents/NUT-Ra-Phytoestrogenes.pdf; 2005. de Cremoux, 2010, Controversies concerning the use of phytoestrogens in menopause management: bioavailability and metabolism, Maturitas, 65, 334, 10.1016/j.maturitas.2009.12.019 Leclercq, 2011, Lack of sufficient information on the specificity and selectivity of commercial phytoestrogens preparations for therapeutic purposes, Maturitas, 68, 56, 10.1016/j.maturitas.2010.10.003 MacLennan, 2001, Oral oestrogen replacement therapy versus placebo for hot flushes, Cochrane Database Syst Rev, 10.1002/14651858.CD002978 Lethaby, 2007, Phytoestrogens for vasomotor menopausal symptoms, Cochrane Database Syst Rev, 10.1002/14651858.CD001395.pub3 Washburn, 1999, Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women, Menopause, 6, 7, 10.1097/00042192-199906010-00004 Upmalis, 2000, Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study, Menopause, 7, 236, 10.1097/00042192-200007040-00005 van de Weijer, 2002, Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo, Maturitas, 42, 187, 10.1016/S0378-5122(02)00080-4 Crisafulli, 2004, Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study, Menopause, 11, 400, 10.1097/01.GME.0000109314.11228.E5 Baber, 1999, Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women, Climacteric, 2, 85, 10.3109/13697139909025571 Quella, 2000, Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial, J Clin Oncol, 18, 1068, 10.1200/JCO.2000.18.5.1068 Scambia, 2000, Clinical effects of a standardized soy extract in postmenopausal women: a pilot study, Menopause, 7, 105, 10.1097/00042192-200007020-00006 Knight, 2001, Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation, Climacteric, 4, 13, 10.1080/713605031 St Germain, 2001, Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment, Menopause, 8, 17, 10.1097/00042192-200101000-00005 Van Patten, 2002, Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial, J Clin Oncol, 20, 1449, 10.1200/JCO.20.6.1449 Nikander, 2003, A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients, Obstet Gynecol, 101, 1213, 10.1016/S0029-7844(03)00232-1 Tice, 2003, Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial, JAMA, 290, 207, 10.1001/jama.290.2.207 Khaodhiar, 2008, Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women, Menopause, 15, 125, 10.1097/gme.0b013e31805c035b Ferrari, 2009, Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms, J Obstet Gynaecol Res, 35, 1083, 10.1111/j.1447-0756.2009.01058.x D’Anna, 2009, Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study, Menopause, 16, 301, 10.1097/gme.0b013e318186d7e2 Bolaños, 2010, Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis, Menopause, 17, 660, 10.1097/gme.0b013e3181cb4fb5 Jou, 2008, Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones, Int J Gynaecol Obstet, 102, 44, 10.1016/j.ijgo.2008.01.028 Setchell, 2001, Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements, J Nutr, 131, 1362S, 10.1093/jn/131.4.1362S Messina, 1991, The role of soy products in reducing risk of cancer, J Natl Cancer Inst, 83, 541, 10.1093/jnci/83.8.541 Goodman, 2009, Urinary excretion and postmenopausal breast cancer risk: the multiethnic cohort study, Cancer Prev Res (Phila), 2, 887, 10.1158/1940-6207.CAPR-09-0039 Peeters, 2003, Phytoestrogens and breast cancer risk. Review of the epidemiological evidence, Breast Cancer Res Treat, 77, 171, 10.1023/A:1021381101632 Duffy, 2007, Implications of phytoestrogen intake for breast cancer, CA Cancer J Clin, 57, 260, 10.3322/CA.57.5.260 Trock, 2006, Meta-analysis of soy intake and breast cancer risk, J Natl Cancer Inst, 98, 459, 10.1093/jnci/djj102 Hirose, 1995, A large-scale, hospital-based case–control study of risk factors of breast cancer according to menopausal status, Jpn J Cancer Res, 86, 146, 10.1111/j.1349-7006.1995.tb03032.x Wu, 1996, Tofu and risk of breast cancer in Asian-Americans, Cancer Epidemiol Biomarkers Prev, 5, 901 Dai, 2001, Population-based case–control study of soyfood intake and breast cancer risk in Shanghai, Br J Cancer, 85, 372, 10.1054/bjoc.2001.1873 Shu, 2001, Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women, Cancer Epidemiol Biomarkers Prev, 10, 483 Wu, 2002, Adolescent and adult soy intake and risk of breast cancer in Asian-Americans, Carcinogenesis, 23, 1491, 10.1093/carcin/23.9.1491 Linseisen, 2004, Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case–control study, Int J Cancer, 110, 284, 10.1002/ijc.20119 Piller, 2006, Plasma enterolactone and genistein and the risk of premenopausal breast cancer, Eur J Cancer Prev, 15, 225, 10.1097/01.cej.0000197449.56862.75 Verheus, 2007, Plasma phytoestrogens and subsequent breast cancer risk, J Clin Oncol, 25, 648, 10.1200/JCO.2006.06.0244 Horn-Ross, 2001, Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study, Am J Epidemiol, 154, 434, 10.1093/aje/154.5.434 Yuan, 1995, Diet and breast cancer in Shanghai and Tianjin, China, Br J Cancer, 71, 1353, 10.1038/bjc.1995.263 Zheng, 1999, Urinary excretion of isoflavonoids and the risk of breast cancer, Cancer Epidemiol Biomarkers Prev, 8, 35 Ingram, 1997, Case–control study of phyto-oestrogens and breast cancer, Lancet, 350, 990, 10.1016/S0140-6736(97)01339-1 Murkies, 2000, Phytoestrogens and breast cancer in postmenopausal women: a case control study, Menopause, 7, 289, 10.1097/00042192-200007050-00003 Thanos, 2006, Adolescent dietary phytoestrogen intake and breast cancer risk (Canada), Cancer Causes Control, 17, 1253, 10.1007/s10552-006-0062-2 McCann, 2006, Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status, Breast Cancer Res Treat, 99, 309, 10.1007/s10549-006-9196-x Key, 1999, Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan, Br J Cancer, 81, 1248, 10.1038/sj.bjc.6690837 Yamamoto, 2003, Soy, isoflavones, and breast cancer risk in Japan, J Natl Cancer Inst, 95, 906, 10.1093/jnci/95.12.906 Lee, 2009, Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study, Am J Clin Nutr, 89, 1920, 10.3945/ajcn.2008.27361 den Tonkelaar, 2001, Urinary phytoestrogens and postmenopausal breast cancer risk, Cancer Epidemiol Biomarkers Prev, 10, 223 Horn-Ross, 2002, Recent diet and breast cancer risk: the California Teachers Study (USA), Cancer Causes Control, 13, 407, 10.1023/A:1015786030864 Keinan-Boker, 2004, Dietary phytoestrogens and breast cancer risk, Am J Clin Nutr, 79, 282, 10.1093/ajcn/79.2.282 Grace, 2004, Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk, Cancer Epidemiol Biomarkers Prev, 13, 698, 10.1158/1055-9965.698.13.5 Zeleniuch-Jacquotte, 2004, Circulating enterolactone and risk of breast cancer: a prospective study in New York, Br J Cancer, 91, 99, 10.1038/sj.bjc.6601893 Kilkkinen, 2004, Serum enterolactone concentration is not associated with breast cancer risk in a nested case–control study, Int J Cancer, 108, 277, 10.1002/ijc.11519 Shu, 2009, Soy food intake and breast cancer survival, JAMA, 302, 2437, 10.1001/jama.2009.1783 Guha, 2009, Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study, Breast Cancer Res Treat, 118, 395, 10.1007/s10549-009-0321-5 McCann, 2002, The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women, J Nutr, 132, 3036, 10.1093/jn/131.10.3036 McCann, 2004, Dietary lignan intakes and risk of pre- and postmenopausal breast cancer, Int J Cancer, 111, 440, 10.1002/ijc.20262 Touillaud, 2007, Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status, J Natl Cancer Inst, 99, 475, 10.1093/jnci/djk096 Sirtori, 2005, Phytoestrogens: end of a tale?, Ann Med, 37, 423, 10.1080/07853890510044586 Labriola, 2009, Natural hormone replacement and breast cancer risk: evidence for safety and efficacy, Oncology, 23, 639 Nelson, 2006, Nonhormonal therapies for menopausal hot flashes, JAMA, 295, 2057, 10.1001/jama.295.17.2057 Balk, 2005, Effects of soy on health outcomes, Evid Rep Technol Assess, 126, 1 This, 2001, Phytoestrogens after breast cancer, Endocr Relat Cancer, 8, 129, 10.1677/erc.0.0080129 Velentzis, 2008, Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know, Eur J Cancer, 44, 1799, 10.1016/j.ejca.2008.05.019